These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 16537431)

  • 1. A dopamine transporter gene functional variant associated with cocaine abuse in a Brazilian sample.
    Guindalini C; Howard M; Haddley K; Laranjeira R; Collier D; Ammar N; Craig I; O'Gara C; Bubb VJ; Greenwood T; Kelsoe J; Asherson P; Murray RM; Castelo A; Quinn JP; Vallada H; Breen G
    Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4552-7. PubMed ID: 16537431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crack cocaine users show differences in genotype frequencies of the 3' UTR variable number of tandem repeats of the dopamine transporter gene (DAT1/SLC6A3).
    Stolf AR; Szobot CM; Halpern R; Akutagava-Martins GC; Müller D; Guimaraes LS; Kessler FH; Pechansky F; Roman T
    Neuropsychobiology; 2014; 70(1):44-51. PubMed ID: 25247548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between the Intron 8 VNTR Polymorphism of the DAT1 Gene and Crack Cocaine Addiction.
    Stolf AR; Müller D; Schuch JB; Akutagava-Martins GC; Guimaraes LSP; Szobot CM; Halpern R; Kessler FHP; Pechansky F; Roman T
    Neuropsychobiology; 2017; 75(3):141-144. PubMed ID: 29332099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between VNTR polymorphisms of the human dopamine transporter gene and expression in post-mortem midbrain tissue.
    Brookes KJ; Neale BM; Sugden K; Khan N; Asherson P; D'Souza UM
    Am J Med Genet B Neuropsychiatr Genet; 2007 Dec; 144B(8):1070-8. PubMed ID: 17579365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventral midbrain correlation between genetic variation and expression of the dopamine transporter gene in cocaine-abusing versus non-abusing subjects.
    Zhou Y; Michelhaugh SK; Schmidt CJ; Liu JS; Bannon MJ; Lin Z
    Addict Biol; 2014 Jan; 19(1):122-31. PubMed ID: 22026501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association study between the DAT1, DBH and DRD2 genes and cocaine dependence in a Spanish sample.
    Fernàndez-Castillo N; Ribasés M; Roncero C; Casas M; Gonzalvo B; Cormand B
    Psychiatr Genet; 2010 Dec; 20(6):317-20. PubMed ID: 20505554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetic role of dopamine transporter (SLC6A3) variation on response to disulfiram treatment for cocaine addiction.
    Kampangkaew JP; Spellicy CJ; Nielsen EM; Harding MJ; Ye A; Hamon SC; Kosten TR; Nielsen DA
    Am J Addict; 2019 Jul; 28(4):311-317. PubMed ID: 31087723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit/hyperactivity disorder.
    Barr CL; Xu C; Kroft J; Feng Y; Wigg K; Zai G; Tannock R; Schachar R; Malone M; Roberts W; Nöthen MM; Grünhage F; Vandenbergh DJ; Uhl G; Sunohara G; King N; Kennedy JL
    Biol Psychiatry; 2001 Feb; 49(4):333-9. PubMed ID: 11239904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine transporter DAT and receptor DRD2 variants affect risk of lethal cocaine abuse: a gene-gene-environment interaction.
    Sullivan D; Pinsonneault JK; Papp AC; Zhu H; Lemeshow S; Mash DC; Sadee W
    Transl Psychiatry; 2013 Jan; 3(1):e222. PubMed ID: 23340505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeat variation in the human PER2 gene as a new genetic marker associated with cocaine addiction and brain dopamine D2 receptor availability.
    Shumay E; Fowler JS; Wang GJ; Logan J; Alia-Klein N; Goldstein RZ; Maloney T; Wong C; Volkow ND
    Transl Psychiatry; 2012 Mar; 2(3):e86. PubMed ID: 22832851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association study of a functional variant in intron 8 of the dopamine transporter gene and migraine susceptibility.
    McCallum LK; Fernandez F; Quinlan S; Macartney DP; Lea RA; Griffiths LR
    Eur J Neurol; 2007 Jun; 14(6):706-7. PubMed ID: 17539957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further evidence for the association between a polymorphism in the promoter region of SLC6A3/DAT1 and ADHD: findings from a sample of adults.
    de Azeredo LA; Rovaris DL; Mota NR; Polina ER; Marques FZ; Contini V; Vitola ES; Belmonte-de-Abreu P; Rohde LA; Grevet EH; Bau CH
    Eur Arch Psychiatry Clin Neurosci; 2014 Aug; 264(5):401-8. PubMed ID: 24487615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association studies of dopamine D4 receptor gene and dopamine transporter gene polymorphisms in Han Chinese patients with attention deficit hyperactivity disorder].
    Qian Q; Wang Y; Li J; Yang L; Wang B; Zhou R
    Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Aug; 35(4):412-8. PubMed ID: 12947560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variation of the dopamine transporter (DAT1) influences the acute subjective responses to cocaine in volunteers with cocaine use disorders.
    Brewer AJ; Nielsen DA; Spellicy CJ; Hamon SC; Gingrich J; Thompson-Lake DG; Nielsen EM; Mahoney JJ; Kosten TR; Newton TF; De La Garza R
    Pharmacogenet Genomics; 2015 Jun; 25(6):296-304. PubMed ID: 25850966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of VNTRs Within the Entire Region of SLC6A3 and Its Association with Hypertension.
    Kim WT; Lee SR; Roh YG; Kim SI; Choi YH; Mun MH; Jeong MS; Koh SS; Leem SH
    DNA Cell Biol; 2017 Mar; 36(3):227-236. PubMed ID: 28055236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 40-bp VNTR polymorphism in the 3'-untranslated region of DAT1/SLC6A3 is associated with ADHD but not with alcoholism.
    Šerý O; Paclt I; Drtílková I; Theiner P; Kopečková M; Zvolský P; Balcar VJ
    Behav Brain Funct; 2015 Jun; 11():21. PubMed ID: 26058807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An association between a dopamine transporter gene (SLC6A3) haplotype and ADHD symptom measures in nonclinical adults.
    Tong JH; Cummins TD; Johnson BP; McKinley LA; Pickering HE; Fanning P; Stefanac NR; Newman DP; Hawi Z; Bellgrove MA
    Am J Med Genet B Neuropsychiatr Genet; 2015 Mar; 168B(2):89-96. PubMed ID: 25656223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of functional dopaminergic gene polymorphisms in the etiology of idiopathic intellectual disability.
    Bhowmik AD; Chaudhury S; Dutta S; Shaw J; Chatterjee A; Choudhury A; Saha A; Sadhukhan D; Kar T; Sinha S; Mukhopadhyay K
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1714-22. PubMed ID: 21609749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional analysis of intron 8 and 3' UTR variable number of tandem repeats of SLC6A3: differential activity of intron 8 variants.
    Hill M; Anney RJ; Gill M; Hawi Z
    Pharmacogenomics J; 2010 Oct; 10(5):442-7. PubMed ID: 20029387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient expression analysis of allelic variants of a VNTR in the dopamine transporter gene (DAT1).
    Mill J; Asherson P; Craig I; D'Souza UM
    BMC Genet; 2005 Jan; 6():3. PubMed ID: 15683546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.